SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-021331
Filing Date
2020-08-04
Accepted
2020-08-04 21:32:41
Documents
1
Period of Report
2020-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14754
  Complete submission text file 0000899243-20-021331.txt   16091
Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94034
Business Address
SUVARI TRICIA BORGA (Reporting) CIK: 0001238408 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 201075397

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations